MCRI
Monarch Casino & Resort, Inc.
MCRI has the edge over NKE overall, supported by stronger fundamentals and stronger modeled upside.
NKE
NIKE, Inc.
NKE offers stronger valuation, but that advantage does not outweigh its weaker overall profile.
MCRI Fundamentals
| Metric | Status |
|---|---|
| Stable | |
| Strong | |
| Strong | |
| Strong |
MCRI's profitability, cash flow and balance sheet are currently strong, and its revenue is stable.
NKE Fundamentals
| Metric | Status |
|---|---|
| Stable | |
| Healthy | |
| Stable | |
| Strong |
NKE's profitability and balance sheet are currently healthy, and its revenue and cash flow are stable.
MCRI PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 16x | $99.43 | -10% |
| Forward | 16x | $111 | — |
| Current | 18x | $111 | — |
| Fair | 19x | $122 | +10% |
| Expensive | 28x | $176 | +58% |
Historical ranges are pointers, not guarantees.
MCRI's PE is in its fair range at 18x. If earnings grow as analysts expect, today's price would be 16x next year's earnings, in its cheap range.
NKE PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Current | 18x | $37.76 | — |
| Cheap | 23x | $47.70 | +26% |
| Forward | 30x | $37.76 | — |
| Fair | 33x | $68.16 | +80% |
| Expensive | 47x | $97.86 | +159% |
Historical ranges are pointers, not guarantees.
NKE has the edge over MCRI in the historical PE scenario, which offers more potential upside but is not a forecast.
MCRI Forward outlook
| Metric | Outlook |
|---|---|
| Improving | |
| Growth | |
| Stable | |
| Strongly improving | |
| Limited | |
| High |
MCRI has the edge over NKE on the outlook, with more favorable valuation and earnings expectations.
NKE Forward outlook
| Metric | Outlook |
|---|---|
| Strongly deteriorating | |
| Stable | |
| Decline | |
| Improving | |
| Moderate | |
| Low |
Analysts expect NKE's profitability to improve, but its revenue to decline. However, they disagree widely on these estimates.
MCRI Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $6.99 | +11% |
| Q3 2026 | $6.31 | +42% |
| Q2 2026 | $6.24 | +48% |
| Q1 2026 | $5.90 | +49% |
| Q4 2025 | $5.43 | +41% |
| Q3 2025 | $4.43 | -2% |
| Q2 2025 | $4.21 | -1.6% |
| Q1 2025 | $3.96 | -6.4% |
| Q4 2024 | $3.84 | -8.6% |
MCRI has the edge over NKE on earnings, with more consistent year-over-year improvement.
NKE Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $1.27 | -39% |
| Q3 2026 | $2.09 | +7.2% |
| Q2 2026 | $2.10 | -2.8% |
| Q1 2026 | $1.51 | -50% |
| Q4 2025 | $1.70 | -48% |
| Q3 2025 | $1.95 | -44% |
| Q2 2025 | $2.16 | -42% |
| Q1 2025 | $3.01 | -11% |
| Q4 2024 | $3.24 | -5.3% |
NKE's earnings per share have fallen from their peak: $2.09 over the past year, against $3.82 in late 2021.
MCRI Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $146.3M | +2.4% |
| Q2 2026 | $142.6M | +4.2% |
| Q1 2026 | $136.6M | +8.9% |
| Q4 2025 | $140M | +4.1% |
| Q3 2025 | $142.8M | +3.6% |
| Q2 2025 | $136.9M | +6.8% |
| Q1 2025 | $125.4M | +3.1% |
| Q4 2024 | $134.5M | +4.9% |
MCRI has the edge over NKE on sales, with more consistent year-over-year improvement.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 28% | +1.5 points |
| Q2 2026 | 27% | +1.6 points |
| Q1 2026 | 26% | +5.4 points |
| Q4 2025 | 21% | +18 points |
| Q3 2025 | 27% | +1.1 points |
| Q2 2025 | 25% | +2.5 points |
| Q1 2025 | 20% | +0.6 points |
| Q4 2024 | 2.9% | -17 points |
MCRI has the edge over NKE on profitability, with a higher operating margin.
NKE Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $11.2B | -4.3% |
| Q2 2026 | $11B | -1.1% |
| Q1 2026 | $11.3B | +0.1% |
| Q4 2025 | $12.4B | +0.6% |
| Q3 2025 | $11.7B | +1.1% |
| Q2 2025 | $11.1B | -12% |
| Q1 2025 | $11.3B | -9.3% |
| Q4 2024 | $12.4B | -7.7% |
NKE's revenue fell from its 2023 peak and has held roughly level since: $11.2B last quarter, down 4.3% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 8.2% | +0.3 points |
| Q2 2026 | 12% | +9.2 points |
| Q1 2026 | 5.8% | -1.7 points |
| Q4 2025 | 8% | -3.4 points |
| Q3 2025 | 7.9% | -3.4 points |
| Q2 2025 | 2.9% | -11 points |
| Q1 2025 | 7.5% | -3.8 points |
| Q4 2024 | 11% | -2.9 points |
NKE's operating margin was 8.2% last quarter, about level with the same quarter a year ago.
MCRI Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $41.9M | -22% |
| Q2 2026 | $25.6M | -1.7% |
| Q1 2026 | $43M | +158% |
| Q4 2025 | $32.2M | +23% |
| Q3 2025 | $53.5M | +51% |
| Q2 2025 | $26M | +138% |
| Q1 2025 | $16.6M | -19% |
| Q4 2024 | $26.2M | +20% |
MCRI has the edge over NKE on cash flow, with more consistent year-over-year improvement.
NKE Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$64M | -527% |
| Q2 2026 | $1.5B | +313% |
| Q1 2026 | $284M | -83% |
| Q4 2025 | $386M | -58% |
| Q3 2025 | $15M | -95% |
| Q2 2025 | $363M | -85% |
| Q1 2025 | $1.7B | -11% |
| Q4 2024 | $920M | -65% |
NKE usually generates cash, though not every quarter: the latest was −$64M, but it generated $2.1B over the past year.
MCRI Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -0.6% | -113K shares |
| 1 year | -3.1% | -588K shares |
| 3 years | -7.4% | -1.5M shares |
| 5 years | -6.6% | -1.3M shares |
| Available history | -2.9% | -536K shares |
MCRI has the edge over NKE on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q3 2026 | $37.4M |
| Q2 2026 | $212,000 |
| Q1 2026 | $17.7M |
| Q4 2025 | $41.4M |
| Q3 2025 | $11.3M |
| Q4 2024 | $63,000 |
| Q3 2024 | $9.7M |
MCRI spent $97M buying back its own shares over the past year.
NKE Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +0.2% | +3.2M shares |
| 1 year | +0.4% | +5.2M shares |
| 3 years | -3.8% | -59.1M shares |
| 5 years | -8.4% | -135M shares |
| Available history | -6.9% | -110M shares |
NKE has 1.5B diluted shares, about the same as a year ago.
| Quarter | Spent |
|---|---|
| Q3 2026 | — |
| Q2 2026 | — |
| Q1 2026 | — |
| Q4 2025 | $20M |
| Q3 2025 | $126M |
| Q2 2025 | $199M |
| Q1 2025 | $506M |
| Q4 2024 | $1.1B |
NKE has spent almost nothing on buybacks in the past year.
MCRI Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | -0.7x | Net Cash |
| Q2 2026 | -0.7x | Net Cash |
| Q1 2026 | -0.6x | Net Cash |
| Q4 2025 | -0.5x | Net Cash |
| Q3 2025 | -0.7x | Net Cash |
| Q2 2025 | -0.5x | Net Cash |
| Q1 2025 | -0.5x | Net Cash |
| Q4 2024 | -0.4x | Net Cash |
MCRI has the edge over NKE on leverage, with a lower net debt burden relative to earnings.
NKE Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 0.2x | Very low |
| Q2 2026 | 0.1x | Very low |
| Q1 2025 | 0.1x | Very low |
| Q4 2024 | 0.2x | Very low |
| Q3 2024 | 0.1x | Very low |
| Q2 2024 | -0.1x | Net Cash |
| Q1 2024 | -0.0x | Very low |
| Q4 2023 | 0.1x | Very low |
NKE's net debt is less than a year of its operating earnings (EBITDA).
MCRI Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 41.4 | Neutral |
| Stochastic | 13.8 | Oversold |
MCRI's weekly RSI is 41 (neutral) and its Stochastic is 14 (oversold).
NKE Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 40.0 | Neutral |
| Stochastic | 57.5 | Neutral |
NKE's weekly RSI is 40 (neutral) and its Stochastic is 58 (neutral).
MCRI PE vs Consumer Cyclical Sector
| Metric | MCRI | Sector median | Relative |
|---|---|---|---|
| PE | 18x | 18x | 2.6% below |
| PE % | 33 | 47 | 14 pts below |
MCRI has the edge over NKE on valuation relative to its sector.
NKE PE vs Consumer Cyclical Sector
| Metric | NKE | Sector median | Relative |
|---|---|---|---|
| PE | 18x | 18x | 0.3% above |
| PE % | 2 | 47 | 45 pts below |
NKE is trading at 18x earnings, in line with the Consumer Cyclical sector's median of 18x.
MCRI Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $113.3 | 2.1% below |
| 20 week MA | $119.4 | 7.2% below |
| 50 week MA | $110.6 | 0.2% above |
| 100 week MA | $100.0 | 11% above |
| 200 week MA | $85.4 | 30% above |
MCRI has the edge over NKE on trend strength, trading above more of its moving averages.
NKE Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $36.7 | 2.8% above |
| 20 week MA | $39.2 | 3.6% below |
| 50 week MA | $48.0 | 21% below |
| 100 week MA | $58.4 | 35% below |
| 200 week MA | $79.2 | 52% below |
NKE has bounced recently, but its long-term trend is still down: it's above its 8-week average, but 52% below its 200-week average.
MCRI Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $48.1 | $59.5 | +24% |
| 2021 | $59.5 | $73.5 | +24% |
| 2022 | $73.5 | $77.0 | +4.7% |
| 2023 | $77.0 | $69.2 | -10% |
| 2024 | $69.2 | $78.1 | +13% |
| 2025 | $78.1 | $98.3 | +26% |
| 2026 YTD | $98.3 | $110.8 | +13% |
MCRI has the edge over NKE on returns for 2026, with the stronger performance.
NKE Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $101.6 | $141.6 | +39% |
| 2021 | $141.6 | $165.7 | +17% |
| 2022 | $165.7 | $116.3 | -30% |
| 2023 | $116.3 | $108.6 | -6.6% |
| 2024 | $108.6 | $76.4 | -30% |
| 2025 | $76.4 | $60.9 | -20% |
| 2026 YTD | $60.9 | $37.8 | -38% |
NKE has finished four years in a row lower, and it's down 38% so far in 2026.